Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)

David Brieger; Frans Van de Werf; Álvaro Avezum; Gilles Montalescot; Brian M. Kennelly; Christopher B. Granger; Shaun G. Goodman; Omar Dabbous; Giancarlo Agnelli

doi:10.1016/j.ahj.2007.03.035

Back

Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)

Article 2007 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Combination therapy with low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)

Giancarlo Agnelli, C. P. Cannon, Frans Van de Werf, Álvaro Avezum, Gilles Montalescot, Wolfgang Lankes, BM Kennelly, Tomasz Mazurek, Rachel Kasper, David Brieger

Article2001

Safety of the combination of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors: observations from the global registry of acute coronary events (GRACE)

CP Cannon, David Brieger, Frans Van de Werf, A Avezum, A Lankes, BM Kennelly, Giancarlo Agnelli, Tomasz Mazurek, Rachel Kasper, Gilles Montalescot

Article2001

Safety of the combination of low-molecular weight heparin and glycoprotein IIb/IIIa inhibitors: observations from the GLobal Registry of Acute Coronary Events (GRACE)

CP Cannon, David Brieger, Frans Van de Werf, A Avezum, Gilles Montalescot, Wolfgang Lankes, BM Kennelly, Giancarlo Agnelli, Tomasz Mazurek, Rachel Kasper

Article2002

Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions

Evangelia Karvouni, Demosthenes G. Katritsis, John P A Ioannidis

Article2003

Effect of intravenous glycoprotein IIb/IIIa receptor antagonists on survival in percutaneous coronary interventions: A meta-analysis

Evangelia Karvouni, Demosthenes G. Katritsis, John P A Ioannidis